Lantheus Holdings (LNTH) Share-based Compensation (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Share-based Compensation came in at $15.7 million in Q1 2026, down 33.74% year-on-year from $23.7 million in Q1 2025, and up 137.65% on a QoQ basis from -$41.7 million in Q4 2025.

Lantheus Holdings (LNTH) Share-based Compensation (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Share-based Compensation data on file, last reported at $15.7 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 33.74% year-over-year to $15.7 million in Q1 2026; TTM through Mar 2026 was $20.8 million, a 149.07% increase from a year earlier, with the FY2025 full-year figure at $26.3 million, up 41706.35% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $15.7 million, up from -$41.7 million in the prior quarter.
  • Over the last five years, Share-based Compensation for LNTH reached as high as $29.3 million in Q4 2022 and fell as low as -$54.2 million in Q4 2024.
  • Historically, Share-based Compensation has averaged $6.5 million across 5 years, with a median of $14.0 million in 2023.
  • On a YoY basis, Share-based Compensation climbed as much as 525.56% in 2024 and fell as far as 255.63% in 2024.
  • Year by year, Share-based Compensation stood at $29.3 million in 2022, then sank by 152.05% to -$15.2 million in 2023, then tumbled by 255.63% to -$54.2 million in 2024, then grew by 23.05% to -$41.7 million in 2025, then soared by 137.65% to $15.7 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $15.7 million in Q1 2026, -$41.7 million in Q4 2025, and $24.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 15.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.70 Mn
Mar 31, 2026 15.70 Mn
Dec 31, 2025 -41.68 Mn
Dec 31, 2025 -41.68 Mn
Sep 30, 2025 24.50 Mn
Sep 30, 2025 24.50 Mn
Jun 30, 2025 22.32 Mn
Jun 30, 2025 22.32 Mn
Mar 31, 2025 23.69 Mn
Mar 31, 2025 23.69 Mn
Dec 31, 2024 -54.17 Mn
Dec 31, 2024 -54.17 Mn
Sep 30, 2024 20.37 Mn
Sep 30, 2024 20.37 Mn
Jun 30, 2024 18.48 Mn
Jun 30, 2024 18.48 Mn
Mar 31, 2024 19.42 Mn
Mar 31, 2024 19.42 Mn
Dec 31, 2023 -15.23 Mn
Dec 31, 2023 -15.23 Mn